CORONARY ATHEROSCLEROSIS

Clinical trials for CORONARY ATHEROSCLEROSIS explained in plain language.

Never miss a new study

Get alerted when new CORONARY ATHEROSCLEROSIS trials appear

Sign up with your email to follow new studies for CORONARY ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Three-Drug combo aims to shrink dangerous heart plaque before it causes a crisis

Disease control Not yet recruiting

This study aims to see if a combination of three cholesterol-lowering drugs can shrink and stabilize fatty plaque buildup in the heart's arteries. It will enroll about 103 adults who have this plaque but have not yet had a heart attack or stroke. Researchers will use special hear…

Matched conditions: CORONARY ATHEROSCLEROSIS

Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

CORONARY ATHEROSCLEROSIS

Get alerted when new CORONARY ATHEROSCLEROSIS trials appear

Three-Drug combo aims to shrink dangerous heart plaque before it causes a crisis